Monitor for future clinical milestones from the NEO100/NEO212 UAE Phase 2 programs and any partnership announcements stemming from the Abu Dhabi Summit. The board appointment of a senior Abu Dhabi banker signals deepening regional ties but provides no near-term catalyst.
Price Chart
Executive Summary
NeOnc Technologies announced the resignation of director Dr. Steven Giannotta and the appointment of Ali Alabedin, Head of Islamic Banking at First Abu Dhabi Bank, to its board. Separately, CEO Amir Heshmatpour will speak at the Abu Dhabi Future Health Summit. These are routine governance changes and conference participation with no financial data or material operational updates.
Key Facts
- Steven L. Giannotta resigned as Class I director effective October 9, 2026; resignation was not due to any disagreement with the company.
- Ali Mohammad Ahmad Alabedin appointed as Class I director effective October 9, 2026, to serve until the 2029 annual meeting.
- Alabedin is Group Head of Islamic Banking at First Abu Dhabi Bank (FAB), the UAE's largest bank with AED 1.41 trillion in total assets.
- CEO Amir Heshmatpour will speak at the Abu Dhabi Future Health Summit 2026 (October 20-22) on a panel about life sciences investment.
- The company has received IND authorization from the Department of Health – Abu Dhabi for both NEO100 and NEO212, supporting Phase 2 development plans in the UAE.
- No financial metrics, guidance, or material agreements were disclosed in this filing.
Financial Impact
No financial impact disclosed; the filing contains only governance changes and a conference participation announcement.
Risk Factors
- Clinical-stage biotech with no approved products; regulatory and clinical trial risks remain high.
- No financial data or guidance provided; the company's cash runway and burn rate are unknown from this filing.
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001829126-26-011189 |
| Document: neonctechnologies_ex99-2.htm | 0001829126-26-011189 |
| Document: neonctechnologies_ex99-1.htm | 0001829126-26-011189 |
| Document: 0001829126-26-011189-index-headers.html | 0001829126-26-011189 |
| Document: 0001829126-26-011189-index.html | 0001829126-26-011189 |
| Document: 0001829126-26-011189.txt | 0001829126-26-011189 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 8-K | $3.27 | awaiting T+60 | — | $2.82 (−13.76%) |
Oct 15, 2026 11d ago | 8-K | $2.70 | awaiting T+60 | — | $2.82 (+4.44%) |
Sep 18, 2026 5w ago | Insider Cluster | $3.33 | awaiting T+60 | — | $2.82 (−15.32%) |
Sep 17, 2026 5w ago | 8-K | $3.41 | awaiting T+60 | — | $2.82 (−17.30%) |
Sep 15, 2026 5w ago | Insider Cluster | $2.99 | awaiting T+60 | — | $2.82 (−5.69%) |
Sep 10, 2026 6w ago | 8-K | $3.66 | awaiting T+60 | — | $2.82 (+22.95%) |
Sep 10, 2026 6w ago | 424B5 | $3.66 | awaiting T+60 | — | $2.82 (+22.95%) |
Aug 20, 2026 9w ago | Insider Cluster | $4.68 | awaiting T+60 | — | $2.82 (−39.68%) |
Aug 18, 2026 9w ago | Insider Cluster | $5.53 | awaiting T+60 | — | $2.82 (−49.01%) |
Aug 12, 2026 10w ago | 8-K | $3.46 | awaiting T+60 | — | $2.82 (−18.50%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers